Appleton Partners Incma buys $2,031,782 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Appleton Partners Incma scooped up 3,505 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 23,378 shares of Cardinal Health Inc which is valued at $2,031,782.Cardinal Health Inc makes up approximately 0.40% of Appleton Partners Incma’s portfolio.

Cardinal Health Inc closed down -0.04 points or -0.05% at $86.54 with 19,07,694 shares getting traded on Wednesday. Post opening the session at $86.89, the shares hit an intraday low of $86.37 and an intraday high of $87.16 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Other Hedge Funds, Including , Lodestar Investment Counselil boosted its stake in CAH in the latest quarter, The investment management firm added 3,445 additional shares and now holds a total of 8,328 shares of Cardinal Health Inc which is valued at $723,786. Cardinal Health Inc makes up approx 0.10% of Lodestar Investment Counselil’s portfolio.Boston Advisors boosted its stake in CAH in the latest quarter, The investment management firm added 13,215 additional shares and now holds a total of 454,543 shares of Cardinal Health Inc which is valued at $39,504,332. Cardinal Health Inc makes up approx 0.97% of Boston Advisors’s portfolio.Breton Hill Capital Ltd. boosted its stake in CAH in the latest quarter, The investment management firm added 497 additional shares and now holds a total of 11,331 shares of Cardinal Health Inc which is valued at $954,637. Cardinal Health Inc makes up approx 0.35% of Breton Hill Capital Ltd.’s portfolio.

On the company’s financial health, Cardinal Health Inc reported $1.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Feb 1, 2016. Analyst had a consensus of $1.26. The company had revenue of $31445.00 million for the quarter, compared to analysts expectations of $29227.04 million. The company’s revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.20 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.